Capsugel, of Morristown, announced Thursday the launch of its Dosage Form Solutions business unit to focus on lipid-based formulations of its technology, while continuing to expand its offerings in targeted release capsules.
Capsugel’s DFS unit has operating sites in North America, Europe and Asia, and has been involved with hundreds of products and projects for specialty, branded and generic pharmaceutical customers.